TECNOTREE
26.2.2024 11:51:29 CET | Business Wire | Press release
Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies announced being awarded a new multimillion-dollar deal with Umniah, a leading provider of a range of telecom solutions in the MENA region with up to 3 million subscribers. With this project, Tecnotree aims to provide AI-embedded BSS customer engagement for the operator. The deal, implementing a full BSS stack along with the Tecnotree Sensa Intelligence platform operationalizes AI across business workflows and is the second win for Tecnotree in terms of AIML-driven customer experience use case.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240226721394/en/
Tecnotree Secures Multimillion-Dollar Deal with Umniah, Pioneering Sensa AIML Embedded BSS Transformation (Photo: Business Wire)
Under this project, Umniah seeks to upgrade its current CRM system with a new CX implementation targeting improvements in NPS, reduction of churn, and an increase in ARPU. As part of the agreement, Tecnotree will deploy Sensa AI-embedded BSS applications streamlining the AI development lifecycle and driving faster time to value across products.
The applications will include a dynamic bundle of product catalogues, digital self-care and customer management, catalogue-driven order management, demand generation through omnichannel campaigns and configurable integration with leading social networks, lead and funnel management, enterprise workforce management with business process orchestration, business intelligence, and analytics capabilities, enterprise and consumer service request management, partner management, E-Shop (marketplace) & B2B self-care portal. The solution will provide the operator with a unified solution with embedded intelligence for transformation across all applications, that enables B2B2X cross-sell and up-sell capabilities.
Faisal Qamhiyah, CEO of Umniah, stated, “Launching the advanced Customer Experience (CX) platform marks a pivotal step in our transformation to revolutionize customer interactions and fulfill their digital age expectations. It demonstrates our dedication to comprehending our customers, engaging with them, and keeping them informed about the digital world's evolving landscape. With customer expectations for seamless, personalized experiences at an all-time high, this platform aims to surpass these demands by providing an in-depth perspective of customer interactions.”
Qamhiyah added, “Umniah envisions a future where its corporate clients excel in understanding and meeting their customers' dynamic needs, driving them towards sustainable growth and success in the digital age.”
Commenting on the new deal, Padma Ravichander, CEO of Tecnotree Corporation, said, “We are very excited to embark on this new chapter with Umniah, as we help them redefine unparalleled digital experiences with the help of our Digital BSS and Sensa AIML fabric, for their business transformation. Our digital BSS stack embedded with Tecnotree Sensa AIML capabilities will enable the customer to improve business agility and respond faster to market dynamics while humanizing experiences and empowering customer journey lifecycle with Sensa hyper-personalisation.”
The transformation will also enable them to optimize operational costs, while significantly improving revenue monetization capability with our AI/ML-based insights and recommendations. The collaboration marks a significant stride for Tecnotree in the field of artificial intelligence, reinforcing our commitment to enhance digital services that create business differentiation and help our customers deliver second-to-none customer experiences”
About Tecnotree
Tecnotree is a 5G-ready digital Business Support System (BSS) player, with AI/ML capabilities and multi-cloud extensibility. Tecnotree leads the way on the TM Forum Open API Conformance with 59 certified Open APIs including 9 real-world open APIs, a testament to the company's commitment to excellence, and continuously striving to deliver differentiated experiences and services to both CSPs and DSPs. Our agile and open-source digital BSS Stack comprises the full range (order-to-cash) of business processes and subscription management for telecom and other digital services industries creating opportunities beyond connectivity. Tecnotree also provides Fintech and B2B2X multi-experience digital marketplace to its subscriber base through the Tecnotree Moments platform to empower digitally connected communities across gaming, health, education, OTT, and other vertical ecosystems. Tecnotree is listed on the Helsinki Nasdaq (TEM1V).
About Umniah
Since its launch in 2005, Umniah, a subsidiary of Beyon Group, has been recognized as one the fastest growing and reliable telecommunications providers in the region’s most competitive markets, offering a wide variety of transformative high-quality mobile, Internet, and enterprise solutions. The award-winning company champions innovation, digital transformation, and technological advancement, delivering to its 3 million subscribers reliability and connectivity through an inclusive range of products and solutions that meet distinctive individual and corporate needs. The company also has a comprehensive and effective sustainability strategy that outlines its environmental, social, and corporate governance practices as well as its commitment to making positive changes in the lives of individuals and society.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240226721394/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States1.7.2026 07:00:00 CEST | Press release
Galderma received a Complete Response Letter from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization Relfydess is approved in 33 markets and already launched in more than 20, including across Europe, the Middle East and Australia, with an encouraging early launch trajectory supported by positive healthcare professional feedback Regulatory filings in other territories are ongoing and remain on track Ad hoc announcement pursuant to Art. 53 LR Galderma (SIX: GALD) today provided progress updates regarding the regulatory review of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA with the U.S. Food and Drug Administration (“FDA”). The Company has received a Complete Response Letter (CRL) from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization. As part of its review, the FDA conducted a Pre-License Inspection (PLI) of Galderma’s manufa
EVE Energy Showcases All-Scenario Energy Storage Solutions at The Smarter E Europe 20261.7.2026 03:45:00 CEST | Press release
EVE Energy unveiled its Mr. Big Family series, a 6.9+ MWh energy storage system, and all-scenario energy storage solutions at Intersolar Europe in Munich. Drawing on traceable large-cell technology, proven large-scale energy storage project delivery experience, and global delivery capabilities, the company is addressing Europe's diverse energy storage requirements across utility-scale, commercial & industrial (C&I ), and data center segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630889717/en/ EVE Energy showcases its Mr. Giant 3.0 6.9+ MWh energy storage system at The Smarter E Europe 2026 in Munich, Germany Advancing Large-Cell Technology with Global Project Validation As one of the first companies to focus on large-capacity energy storage cells, EVE Energy has iteratively upgraded its cell platform from 560 Ah and 628 Ah to 702 Ah, adhering to a stacking process route throughout. At the exhibition, the Mr. Gia
Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 01:56:00 CEST | Press release
Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom